辅助用药全程化管控实践  

The Whole Process Control Practice of Adjuvant Medication

作　　者：杨彧[1] 钱卿[1] 陈荣[1] 倪慧萍[1] 周军[1] 周瑞珏[1] 王莉英[1] YANG Yu;QIAN Qin;CHEN Rong(The Third Affiliated Hospital of Soochow University,Changzhou,Jiangsu,213003,China)

机构地区：[1]苏州大学附属第三医院,江苏常州213003

出　　处：《中国卫生质量管理》2020年第2期10-12,共3页Chinese Health Quality Management

基　　金：2018年江苏现代医院管理研究基金项目(JSY-3-2018-077);2018年江苏现代医院管理研究基金项目(JSY-3-2018-086)。

摘　　要：在传统的点评、反馈及事后干预模式下,以"互联网+"技术为基础,通过制度制订、规则制订、系统构造和目标制订4大模块的建立,构建了基于HIS系统的辅助用药全程化管控体系,实现了对辅助用药使用的实时统计、监督以及总量管控和动态监管。该体系上线运行后,辅助药物使用总金额由2016年5月的1943.92万元降低至2019年3月的413.38万元,人均辅助用药费用由2525.24元下降至313.48元,药占比从42%降低到30%左右,各科室辅助用药强度也明显下降。In traditional comments,feedback,and post-intervention mode,on the basis of"Internet plus"technology,through the establishment of four modules of system formulation,rules formulation,system structure and the target formulation,the whole process control system of adjuvant medication based on hospital information system(HIS)was established,which realized the real-time statistics,supervision,total control and dynamic supervision of adjuvant medication use.After the system was put into operation,the total amount of adjuvant medication was reduced from 1943.92 ten thousand Yuan in May 2016 to 413.38 ten thousand Yuan in March 2019,the per capita cost of auxiliary drugs was reduced from 2525.24 yuan to 313.48 yuan,and the per capita cost of adjuvant medication use decreased from 2525.24 yuan to 313.48 yuan,and the proportion of medication decreased from 42%to about 30%.The intensity of adjuvant medication use in all departments also decreased significantly.

关 键 词：HIS系统 辅助用药 全程管控体系 

分 类 号：R197.323[医药卫生—卫生事业管理] R95[医药卫生—公共卫生与预防医学]